Andreas Bohrer
Prof. Dr. iur., Attorney, LL.M.
Mobile +41 79 865 8567 Group General Counsel [email protected] and Company Secretary [email protected] SSRN Publications of Andreas Bohrer Lonza Group AG, Basel University of Zurich website Andreas Bohrer Vanguard Law Magazine featuring Andreas Bohrer
Expertise: Education: Andreas Bohrer is Group General Counsel and 2011 Harvard Executive Forum, USA Company Secretary at Lonza Group AG. Previously 2011 Titularprofessor, University of Zurich with Novartis, UBS, law firms in Zurich/Geneva and 2008 INSEAD, IEP, Paris/Singapore New York. Titularprofessor at Zurich University, lecturer on Corporate Governance and Capital Markets law. 2004 Habilitation, University of Zurich 1997/98 LL.M. (NYU); Fulbright Scholar Practice Areas: 1995-97 Dr. iur.; bar exam; lic. iur., Zurich General Counsel roles in Pharma, Banking and Asset Management. Board and Corporate Governance Board-related Experience: experience. M&A/Transactions in US and Switzerland. – Company Secretary of Lonza, a Swiss SMI® Professional Experience: blue chip company with dual listing (Board and Executive Committee). IMD Board Education 2015- Group General Counsel and Company Program, Lausanne 2015 Lonza Secretary, Lonza Group (Swiss SMI® blue chip company with dual listing), – Board member in banking and non-financial reporting to the CEO. Acquisition / sector (including venture incubator) integration of Capsugel. – Member of various Group subsidiary boards in In charge of Legal, Ethics&Compliance Switzerland and world-wide, in the financial and and IP, Environment/Health/Safety non-financial sector. (EHS) and Sustainability, Region India
and South America. Extra-curricular activities, networks: – Member of the Board of SwissHoldings, the 2010-15 2014-2015, General Counsel and Association of industrial and service groups in Novartis member of the Executive Committee, Switzerland, 2015-2017. Co-Chair of Corporate Novartis Animal Health Division. In and Capital Market Law Committee, 2018- charge of Legal, Compliance and IP globally. Integration into Eli Lilly & Co. – Pro bono Trustee, Stiftung Europainstitut of the University of Basel; Co-Chair, Internationale 2010-2014, Head Legal Transactions, Bach-Gesellschaft (IBG) Schaffhausen. Novartis Group: M&A, VC, Antitrust, – Alumnus, American-Swiss Young Leaders Capital Markets & Corporate Law, Conference, 2009; Stars – the Symposium for Procurement, IT & Outsourcing, Social Leaders of the Next Generation, 2012. Media, HR. USD 50bn acquisition of Alcon by Novartis. – Military: 1st lieutenant, intelligence officer, air transport squadron, Swiss Air Force (until 2005) 2003-10 2009-2010, General Counsel Switzer- – Languages: German and English (fluent); land, UBS AG. Member of Executive UBS French and Italian (intermediate); Chinese Committee UBS Switzerland. (Mandarin) and Russian (beginner). 2004-2009, General Counsel and Chief Risk Officer EMEA, UBS Global Publications & Academic activities: Asset Management. Member of the – Max Planck Institute, Hamburg, yearly European Management Committee. German/Austrian/Swiss corporate and capital 2003-2004, Executive Director with market law expert symposium, since 2010 UBS Group Legal in Zurich, in charge – Harvard & Stanford Law Schools, USA, 2009 of the UBS own-account M&A. International Junior Faculty Forum 1999-2003 Corporate attorney with Lenz & – Habilitation thesis „Corporate Governance Staehelin in Zurich and Geneva. and Capital Market Transactions“, Zurich 2005 1995-1997 Trainee/associate (incl. bar exam). – Ph.D. thesis on Unfriendly Takeovers under 1998-99 Corporate associate with Covington & Swiss law, Zurich 1997 Burling (Howard Smith & Levin) in – Winner of a First Prize of the Zurich University New York. Prize Institute, 1993.